Christopher Lloyd

MEDI1814 selectively reduces free Aβ42 in cerebrospinal fluid of non-clinical species and Alzheimer's disease patients.

N. Proctor, J. Dage, F. Natanegara, 2024, Alzheimer's & dementia : the journal of the Alzheimer's Association.